丁酸钠通过调节肠道通透性和黏蛋白表达改善CKD大鼠胰岛素抵抗和肾衰竭
该研究在5/6肾切除诱导的CKD大鼠模型中,发现肠道屏障破坏导致LPS漏出并降低胰岛素敏感性。丁酸钠治疗通过增加结肠黏蛋白和紧密连接蛋白改善肠道屏障功能,进而改善胰岛素抵抗和肾功能。
要点
- CKD大鼠存在肠道屏障破坏、LPS漏出和胰岛素抵抗。
- 丁酸钠增加结肠黏蛋白和紧密连接蛋白,强化肠壁。
- 丁酸钠改善胰岛素抵抗和肾衰竭指标。
核心结论
- 丁酸钠通过增加AMPK磷酸化、促进GLP-1分泌和增加结肠黏蛋白及紧密连接蛋白,强化肠道屏障,减少LPS漏出和炎症,从而改善CKD动物的胰岛素抵抗和肾衰竭指标。
研究设计与样本
- 研究使用5/6肾切除(Nx)诱导肾衰竭的大鼠模型,Nx组和对照组部分大鼠在饮水中接受丁酸钠,Nx组与假手术对照比较。
主要发现
- Nx大鼠血清肌酐、尿素和蛋白尿显著增加,并出现葡萄糖和胰岛素耐量受损及糖异生增加,对应GLP-1分泌减少。
- Nx动物肠道紧密连接蛋白、结肠黏蛋白和黏蛋白2蛋白显著丢失,伴随循环LPS显著增加,提示肠漏现象。
- Nx组肠道AMPK磷酸化显著降低,抗炎细胞因子IL-10、抗菌肽和cathelicidin相关抗菌肽也降低。
- 丁酸钠治疗增加AMPK磷酸化,改善肾功能并控制高血糖。
临床怎么用
- 丁酸钠可能通过改善肠道屏障功能为CKD相关代谢紊乱和肾衰竭提供治疗思路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The associated increase in the lipopolysaccharide (LPS) levels and uremic toxins in chronic kidney disease (CKD) has shifted the way we focus on intestinal microbiota. This study shows that a disruption of the intestinal barrier in CKD promotes leakage of LPS from the gut, subsequently decreasing insulin sensitivity. Butyrate treatment improved the intestinal barrier function by increasing colonic mucin and tight junction (TJ) proteins. This modulation further ameliorated metabolic functions such as insulin intolerance and improved renal function. METHODS: Renal failure was induced by 5/6th nephrectomy (Nx) in rats. A group of Nx and control rats received sodium butyrate in drinking water. The Nx groups were compared with sham-operated controls. RESULTS: The Nx rats had significant increases in serum creatinine, urea and proteinuria. These animals had impaired glucose and insulin tolerance and increased gluconeogenesis, which corresponded with decreased glucagon-like peptide-1 (GLP-1) secretion. The Nx animals suffered significant loss of intestinal TJ proteins, colonic mucin and mucin 2 protein. This was associated with a significant increase in circulating LPS, suggesting a leaky gut phenomenon. 5'adenosine monophosphate-activated protein kinase (AMPK) phosphorylation, known to modulate epithelial TJs and glucose metabolism, was significantly reduced in the intestine of the Nx group. Anti-inflammatory cytokine, interleukin 10, anti-bacterial peptide and cathelicidin-related antimicrobial peptide were also lowered in the Nx cohort. Butyrate treatment increased AMPK phosphorylation, improved renal function and controlled hyperglycemia. CONCLUSIONS: Butyrate improves AMPK phosphorylation, increases GLP-1 secretion and promotes colonic mucin and TJ proteins, which strengthen the gut wall. This decreases LPS leakage and inflammation. Taken together, butyrate improves metabolic parameters such as insulin resistance and markers of renal failure in CKD animals.
引用
- Gonzalez A, Krieg R, Massey HD, et al. Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression. Nephrol Dial Transplant. 2019. PMID: 30085297. doi:10.1093/ndt/gfy238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。